Skip to main content
☩ AI Health Guide
Menu
Affiliate disclosure: This page contains affiliate links marked with ↗. If you sign up through one of these links, we earn a commission at no extra cost to you. Our rankings and reviews are editorially independent — affiliate relationships do not influence them. Health claims have not been verified by the FDA. Read our methodology →
Last Updated:

Glass Health Review 2026: AI Clinical Decision Support for Diagnosis

A

AI Health Apps Editorial Team

Editorial Team, AI Health Guide

Updated

Reviewed against our methodology

About the editorial team  ·  Report an error

Verdict

Glass Health is one of the strongest AI clinical decision-support (CDS) tools for physicians, residents, and medical students seeking AI-assisted differential diagnosis and clinical reasoning. Founded in 2021, Glass uses LLM-based reasoning over a curated medical knowledge base — the differential outputs are explainable, source-cited, and tuned for clinical workflow rather than consumer use.

Glass occupies a similar niche to OpenEvidence (peer-reviewed-literature search) and traditional reference tools (UpToDate, DynaMed) but with a stronger AI-reasoning layer that synthesises across cases. For experienced clinicians, it's a useful "second opinion" surface. For residents and medical students, it's particularly valuable for building differential-diagnosis intuition.

What Glass Health does

Two primary surfaces:

  • Glass AI: input a one-line clinical scenario ("65-year-old female with chest pain radiating to jaw, mild dyspnoea, hypertension history") and get a structured differential diagnosis with reasoning, ranked by probability, and explanation of key discriminating findings to look for next.
  • Glass Notebooks: a knowledge-management surface where clinicians can save, organise, and revisit clinical pearls, differentials, and reference notes. Shareable across teams.

Pricing

  • Free tier: Limited Glass AI queries per month plus unlimited basic Notebook use. Sufficient for occasional reference and student use.
  • Pro: Subscription pricing varies; typically positioned as professional-tier monthly or annual. Adds higher query limits, advanced reasoning, and team features.
  • Enterprise: Custom pricing for residency programs, health systems, and team deployments.

Verify current pricing on glass.health — pricing iterates. Many users get sufficient value from the free tier for occasional reference use.

Strengths

  • Strong differential-diagnosis quality. Differentials are clinically reasonable, ranked appropriately, and include the discriminating findings that experienced clinicians look for. Particularly useful for unfamiliar presentations or zebra differentials.
  • Source-cited reasoning. Glass shows the reasoning behind its differential and cites the underlying knowledge base. This is important for clinical use — you can verify why the AI is suggesting what it's suggesting.
  • Notebooks are useful. The knowledge-management layer is a real product, not an afterthought. Useful for residents and students building their own reference repository over time.
  • Active development and academic partnerships. Glass has academic partnerships with several US medical schools and is actively iterating on the model. Quality is improving in 2026 vs 2024 launches.
  • Privacy-first design. Glass is designed for clinician use, not patient input. Clinicians enter de-identified clinical scenarios; the platform's privacy posture is closer to a clinical reference tool than a patient-facing app.

Weaknesses

  • Not a medical device. Glass is positioned as decision support, not diagnostic AI. It does not have FDA clearance and should not be used as the sole basis for clinical decision-making. Clinicians remain liable.
  • Smaller knowledge base than UpToDate / DynaMed. Glass excels at AI reasoning over its base, but the base itself is smaller than mature subscription clinical references. For deep-dive clinical literature, OpenEvidence (peer-reviewed-paper search) and UpToDate (curated comprehensive content) remain stronger.
  • LLM hallucination risk. Like all LLM-based clinical AI, Glass can occasionally generate plausible-sounding but incorrect output. The source-citation layer mitigates this, but clinical reasoning over the output is essential — never accept a differential or treatment recommendation without verification.
  • Pricing transparency. Public pricing for Pro tier is less clear than for, say, OpenEvidence (free for clinicians) or UpToDate (well-documented subscription rates). Clinicians evaluating Glass for personal use need to inquire.
  • Not EHR-integrated. Glass operates as a stand-alone tool. No native Epic, Cerner, or athena integration. Clinicians use it alongside the EHR, not within it.

Glass Health vs OpenEvidence vs UpToDate

  • Glass Health — AI-reasoning differential diagnosis. Best for clinical scenarios, residency learning, and AI-assisted reasoning.
  • OpenEvidence — AI-powered peer-reviewed literature search. Best for "what does the recent evidence say about X?" Free for clinicians.
  • UpToDate — curated comprehensive clinical reference (not primarily AI). Best for deep-dive review of established clinical topics. Subscription required.

These tools are complementary, not competing. Many clinicians use Glass for differential-diagnosis reasoning, OpenEvidence for evidence search, and UpToDate for established clinical-decision protocols. None replaces clinical judgement.

Bottom line

Glass Health is a strong AI-reasoning clinical decision-support tool with explainable, source-cited differential diagnosis. For physicians and residents who want an AI "second opinion" surface, Glass is one of the best options in the category. The free tier is sufficient for occasional reference use; Pro and Enterprise tiers are appropriate for clinicians who use it daily or teams sharing notebooks. Glass does not replace clinical judgement, EHR-native CDS, or comprehensive references like UpToDate — it complements them.

Frequently asked questions

Is Glass Health for patients or doctors?
Doctors. Glass Health is positioned and built for clinician use — it expects clinical-language input and produces clinically-framed output. Patients seeking a symptom checker should use a consumer tool such as Ada Health, not Glass.
Is Glass Health FDA-cleared?
No. Glass is positioned as clinical decision support, not diagnostic AI, and does not require FDA clearance under current guidance. Clinicians using Glass remain liable for clinical decisions; the tool is decision support, not a medical device.
Glass Health vs OpenEvidence — which is better?
They serve different purposes. Glass excels at AI-reasoning differential diagnosis (what could be wrong with this patient?). OpenEvidence excels at AI-powered peer-reviewed literature search (what does the evidence say about this?). Many clinicians use both. OpenEvidence is free for clinicians; Glass has a free tier with paid upgrade.
Can Glass replace UpToDate?
No. UpToDate offers curated, comprehensive clinical reference content covering established protocols and decision-making — Glass's knowledge base is smaller. For deep-dive review of established clinical topics, UpToDate remains stronger. Glass is a complement for AI-reasoning over scenarios.
Will Glass hallucinate medical information?
Possibly — like all LLM-based clinical AI, Glass can occasionally generate plausible-sounding but incorrect output. The source-citation layer mitigates this, and Glass is generally more conservative than general-purpose LLMs. Always verify clinical reasoning against primary sources before acting on Glass output.
Is Glass HIPAA compliant?
Glass is designed for de-identified clinical scenarios entered by clinicians, not for processing PHI. For team / enterprise deployments where Glass would handle PHI under a covered-entity relationship, Glass offers Business Associate Agreements (BAAs). Verify current BAA terms with Glass sales for HIPAA-bound use.
For Clinicians: Freed Try Freed ↗